Financial Highlights (Quarter)

2025 2Q（6 months）ended September 30, 2024

Overall sales decreased 0.7% over the same period of the previous fiscal year. In Japan, the Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. Domestic sales increased, because sales of consumables and services increased, while there was a reactionary decline in sales of IT systems compared to the strong growth due to large orders in the same period of the previous fiscal year. Sales of Patient Monitors and Physiological Measuring Equipment decreased due to lower sales of IT systems. Sales of Other Medical Equipment remained flat. Sales of Treatment Equipment increased favorably, mainly due to sales of AEDs, defibrillators, and ablation catheters. Overseas sales decreased, due to the impact of a change in the fiscal term of Defibtech, LLC according to the reorganization of subsidiaries in the U.S. in the same period of the previous fiscal year. Another reason was that sales in Asia & Other decreased, mainly in China. Sales of Treatment Equipment and Physiological Measuring Equipment decreased, while sales of Patient Monitors and Other Medical Equipment increased.

*In the previous fiscal year, Defibtech, LLC changed its fiscal term from end on December 31 to end on March 31, according to the reorganization of U.S. subsidiaries. In the first half ended September 30, 2023, Nihon Kohden consolidated the 9 months of Defibtech’s operating results from January 1, 2023 to September 30, 2023.

2025 2Q（6 months）ended September 30, 2024

Operating Income decreased 31.7%, due to decreased sales and increased SG&A expenses caused by strengthening of human resources and wage increases.

2025 2Q（6 months）ended September 30, 2024

Ordinary income decreased 82.9%, reflecting foreign exchange losses compared to gains in the same period of the previous fiscal year.

2025 2Q（6 months）ended September 30, 2024

Income attributable to owners of parent decreased 94.2%, as the Company posted extraordinary losses such as loss on business restructuring in Shanghai Kohden Medical Electronic Instrument Corp. due to lower demand for medical equipment in China.